Compare BOXL & HSCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BOXL | HSCS |
|---|---|---|
| Founded | 1985 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Telecommunications Equipment | Medical Specialities |
| Sector | Telecommunications | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.3M | 7.5M |
| IPO Year | 2017 | 2022 |
| Metric | BOXL | HSCS |
|---|---|---|
| Price | $0.87 | $2.69 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 2 |
| Target Price | N/A | ★ $10.50 |
| AVG Volume (30 Days) | ★ 155.9K | 36.4K |
| Earning Date | 11-06-2025 | 12-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $106,608,000.00 | $6,250.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.73 | $2.01 |
| 52 Week High | $10.65 | $6.47 |
| Indicator | BOXL | HSCS |
|---|---|---|
| Relative Strength Index (RSI) | 37.44 | 42.26 |
| Support Level | $0.81 | $2.55 |
| Resistance Level | $0.91 | $3.00 |
| Average True Range (ATR) | 0.08 | 0.23 |
| MACD | 0.03 | 0.02 |
| Stochastic Oscillator | 32.16 | 29.69 |
Boxlight Corp is a technology company that develops, sells, and services interactive solutions predominantly for the education market but also for the corporate and government sectors. The company currently designs, produces, and distributes interactive technologies, including interactive and non-interactive flat panel displays, LED video walls, media players, classroom audio and campus communication, cameras, and other peripherals for the education market and non-interactive solutions including flat panels, LED video walls, and digital signage. The company also distributes science, technology, engineering, and math (or STEM) products, including 3D printing and robotics solutions and a portable science lab.
HeartSciences Inc is an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease. Its objective is to improve healthcare by making it a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings. It is developing a suite of AI-ECG diagnostic solutions for use in any healthcare care setting, either via MyoVista Insights cloud-platform using one of the millions of ECG devices currently in clinical use or via MyoVista wavECG Device.